OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York
Anthony P. West, Joel O. Wertheim, Jade Wang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Zijun Wang, Frauke Muecksch, Dennis Schaefer-Babajew, et al.
Nature (2021) Vol. 595, Iss. 7867, pp. 426-431
Open Access | Times Cited: 742

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 402

Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection
Allison J. Greaney, Andrea N. Loes, Lauren E. Gentles, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 600
Open Access | Times Cited: 241

High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape
Fabian Schmidt, Yiska Weisblum, Magdalena Rutkowska, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 512-516
Open Access | Times Cited: 218

SARS-CoV-2 Mutations and their Viral Variants
Begüm Coşar, Zeynep Yağmur KARAGÜLLEOĞLU, Sinan ÜNAL, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 63, pp. 10-22
Open Access | Times Cited: 179

Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York
Medini K. Annavajhala, Hiroshi Mohri, Pengfei Wang, et al.
Nature (2021) Vol. 597, Iss. 7878, pp. 703-708
Open Access | Times Cited: 119

The emerging SARS-CoV-2 variants of concern
Adekunle Sanyaolu, Chuku Okorie, Aleksandra Marinkovic, et al.
Therapeutic Advances in Infectious Disease (2021) Vol. 8
Open Access | Times Cited: 118

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
Satoshi Ikegame, Mohammed Nure Alam Siddiquey, Chuan-Tien Hung, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 110

Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations
Sheikh Bilal Ahmad, Maria Batool, Quratul Ain, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9124-9124
Open Access | Times Cited: 109

COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences
Berenice Martínez-Salazar, Melle Holwerda, Chiara Stüdle, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 86

An early warning system for emerging SARS-CoV-2 variants
Lorenzo Subissi, Anne von Gottberg, Lipi Thukral, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1110-1115
Open Access | Times Cited: 69

Current status of therapeutic monoclonal antibodies against SARS-CoV-2
Sanjeev Kumar, Anmol Chandele, Amit Sharma
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009885-e1009885
Open Access | Times Cited: 97

Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
Shang Yu Gong, Debashree Chatterjee, Jonathan Richard, et al.
Virology (2021) Vol. 563, pp. 134-145
Open Access | Times Cited: 85

Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective
Sarah Halawa, Soni Savai Pullamsetti, Charles R. M. Bangham, et al.
Nature Reviews Cardiology (2021) Vol. 19, Iss. 5, pp. 314-331
Open Access | Times Cited: 71

SARS-CoV-2 variants, immune escape, and countermeasures
Yi Zhang, Haocheng Zhang, Wenhong Zhang
Frontiers of Medicine (2022) Vol. 16, Iss. 2, pp. 196-207
Open Access | Times Cited: 65

The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
Pedro F.N. Souza, Felipe Pantoja Mesquita, Jackson L. Amaral, et al.
International Journal of Biological Macromolecules (2022) Vol. 208, pp. 105-125
Open Access | Times Cited: 59

Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach
Taj Mohammad, Arunabh Choudhury, Insan Habib, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 58

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
Jérémie Prévost, Jonathan Richard, Romain Gasser, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 4, pp. 101151-101151
Open Access | Times Cited: 56

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
Fuxing Lou, Maochen Li, Zehan Pang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 55

Enabling accurate and early detection of recently emerged SARS-CoV-2 variants of concern in wastewater
Nicolae Sapoval, Yunxi Liu, Esther G. Lou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21

SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants
Dima Hattab, Mumen F. A. Amer, Zina M. Al‐Alami, et al.
Infection (2024) Vol. 52, Iss. 3, pp. 767-786
Open Access | Times Cited: 13

Spike2Vec: An Efficient and Scalable Embedding Approach for COVID-19 Spike Sequences
Sarwan Ali, Murray Patterson
2021 IEEE International Conference on Big Data (Big Data) (2021), pp. 1533-1540
Open Access | Times Cited: 54

Page 1 - Next Page

Scroll to top